ENTRY       N00047                      Network
NAME        EML4-ALK fusion kinase to PI3K signaling pathway
DEFINITION  EML4-ALK -> PI3K -> PIP3 -> AKT -| BAD
  EXPANDED  (238v1,238v2) -> (5290,5291,5293) -> C05981 -> (207,208,10000) -| 572
CLASS       nt06214 PI3K signaling
            nt06266 Non-small cell lung cancer
TYPE        Variant
PATHWAY     hsa05223  Non-small cell lung cancer
DISEASE     H00014  Non-small cell lung cancer
GENE        238  ALK; ALK receptor tyrosine kinase
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
            207  AKT1; AKT serine/threonine kinase 1
            208  AKT2; AKT serine/threonine kinase 2
            10000  AKT3; AKT serine/threonine kinase 3
            572  BAD; BCL2 associated agonist of cell death
VARIANT     238v1  EML4-ALK fusion
            238v2  First generation TKI-resistant ALK1 mutation
METABOLITE  C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:23201355
  AUTHORS   Roskoski R Jr
  TITLE     Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition.
  JOURNAL   Pharmacol Res 68:68-94 (2013)
            DOI:10.1016/j.phrs.2012.11.007
REFERENCE   PMID:19629074
  AUTHORS   Janne PA, Gray N, Settleman J
  TITLE     Factors underlying sensitivity of cancers to small-molecule kinase inhibitors.
  JOURNAL   Nat Rev Drug Discov 8:709-23 (2009)
            DOI:10.1038/nrd2871
REFERENCE   PMID:25806180
  AUTHORS   Raghav KP, Gonzalez-Angulo AM, Blumenschein GR Jr
  TITLE     Role of HGF/MET axis in resistance of lung cancer to contemporary management.
  JOURNAL   Transl Lung Cancer Res 1:179-93 (2012)
            DOI:10.3978/j.issn.2218-6751.2012.09.04
REFERENCE   PMID:24091716
  AUTHORS   Solomon B, Wilner KD, Shaw AT
  TITLE     Current status of targeted therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer.
  JOURNAL   Clin Pharmacol Ther 95:15-23 (2014)
            DOI:10.1038/clpt.2013.200
///
